Poliovirus vaccine oral - Bilthoven Biologicals

Drug Profile

Poliovirus vaccine oral - Bilthoven Biologicals

Alternative Names: BBio Bivalent Oral Polio Vaccine - Bilthoven Biologicals; BBio bOPV - Bilthoven Biologicals

Latest Information Update: 01 Jun 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bilthoven Biologicals
  • Developer Serum Institute of India
  • Class Viral vaccines; Viruses
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Poliomyelitis

Most Recent Events

  • 01 May 2016 Phase-III clinical trials in Poliomyelitis (In children, In infants, Prevention) in Bangladesh (PO) (NCT02766816)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top